Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Prospective, Multinational, Multicentre Study Comparing the Effectiveness of Safinamide, Rasagiline and Other "Standard Of Care" as Add-On Therapy to Levodopa (L-Dopa) in Parkinson's Disease (Pd) Fluctuating Patients

NCT03994328 is registered in ClinicalTrials.gov with Zambon SpA as lead sponsor.

NCT NCT03994328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Prospective, Multinational, Multicentre Study Comparing the Effectiveness of Safinamide, Rasagiline and Other "Standard Of Care" as Add-On Therapy to Levodopa (L-Dopa) in Parkinson's Disease (Pd) Fluctuating Patients
Lead sponsor
Zambon SpA
Phase
Observational
Overall status
Completed
Start date
December 3, 2019
Completion date
December 31, 2023
Enrollment
1,235 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease